OCT 24, 2016 6:30 AM PDT

Cost of care slows young adults' heart attack recovery

Image Credit: Getty Images

In the year following a heart attack, young men and women who face financial barriers to care may experience worse health outcomes, a new study suggests.

The national study of a group of young adults with myocardial infarction found that those who reported experiencing financial barriers to healthcare services and medication reported worse quality of life, more depressive symptoms, poorer psychosocial status, and more stress than patients without financial barriers, both while in the hospital and 12 months later.

“Despite the expansion of insurance coverage, young adults face major challenges to obtaining affordable healthcare,” says first author Adam Beckman, a 2016 graduate of Yale College and the Yale Global Health Scholars program.

“We suspected women may experience greater challenges than men—they often have lower income and less complete medical coverage than men, and care for multiple generations of family, and that this may in part explain why young women have worse outcomes following a heart attack as compared with similarly-aged men.”

For the study, published in the Journal of the American Heart Association, researchers surveyed 3,437 patients with a heart attack (ages 18-55) both one month and 12-months after their hospitalization. The patients were from the VIRGO study (Recovery in Variation: Role of Gender on Outcomes of Young AMI Patients), a trial observing younger patients after heart attack, particularly women, from the United States and Spain.

The findings show that nearly one in three young adults reported financial barriers to health care services and about one in five reported financial barriers to medications, women more so than men. “Contrary to our hypothesis, both men and women who reported having a financial barrier were significantly worse off one year after their heart attack,” Beckman says.

“Our study emphasizes that patients need us to think about their social needs, not just their clinical symptoms,” says senior author Erica Spatz, assistant professor of medicine at Yale School of Medicine and a clinical investigator at the Yale Center for Outcomes Research & Evaluation (CORE).

“We have not completed our job if we discharge patients from the hospital and recommend they use medications or services like cardiac rehab that they cannot afford.”

The National Heart, Lung, and Blood Institute partially funded the study.

Source: Yale University

This article was originally published futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
FEB 10, 2020
Cardiology
FEB 10, 2020
Blocking Problem Protein Shows Promise for Preventing Heart Attacks
Over time, atherosclerosis, a disease that causes fatty plaques to build up in the arteries, limits the flow of oxygen-r ...
MAR 20, 2020
Cardiology
MAR 20, 2020
Exercise For Persons With COPD
The thought of starting an exercise program can be daunting, particularly for those who have been diagnosed with chronic ...
APR 23, 2020
Cardiology
APR 23, 2020
Blood Pressure Spikes in Young Adults Linked to Heart Disease Later on
Researchers have found that young adults in their 20’s and 30’s who experience inconsistent blood pressure m ...
APR 30, 2020
Cardiology
APR 30, 2020
Pregnancy Issues May be Associated with Future Heart Problems
New research presented at the American College of Cardiology Scientific Session virtual meeting found that a history of ...
MAY 20, 2020
Cardiology
MAY 20, 2020
Metabolite Responsible for Poor Metabolic Response to Exercise Identified
For some, working out just doesn’t pay off. A recent study published in Cardiovascular Research by the H ...
MAY 25, 2020
Drug Discovery & Development
MAY 25, 2020
Hydrochloroquine Increases Risk of Death by COVID-19
Researchers have found that hydroxychloroquine is not an effective treatment for COVID-19. Their study found that it lea ...
Loading Comments...